Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice

被引:42
作者
Choi, IH
Shin, YM
Park, JS
Lee, MS
Han, EH
Chai, OH
Im, SY
Ha, TY
Lee, HK [1 ]
机构
[1] Chonbuk Natl Univ, Sch Med, Dept Immunol, Chonju 561182, Chonbuk, South Korea
[2] Chonbuk Natl Univ, Sch Med, Inst Med Sci, Chonju 561182, Chonbuk, South Korea
[3] Chonbuk Natl Univ, Sch Med, Dept Anat, Chonju 561182, Chonbuk, South Korea
[4] Chonnam Natl Univ, Coll Nat Sci, Dept Microbiol, Kwangju 500757, South Korea
[5] Chonnam Natl Univ, Coll Nat Sci, Hormone Res Ctr, Kwangju 500757, South Korea
关键词
mast cells; W/W-v mice; immunoglobulin E; platelet-activating factor; penicillin V;
D O I
10.1084/jem.188.9.1587
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells have long been believed to be the central effector cells in the development of immunoglobulin (Ig)E-dependent anaphylaxis. In this study, we investigated the role of mast cells in IgE-dependent hapten-induced active fatal anaphylaxis using mast cell-deficient WBB6F1-W/W-v (W/W-v) and congenic normal (+/+) mice. Although a 5-min delay in shock signs and death were observed in W/W-v mice, 100% fatal reactions to penicillin V (Pen V) occurred in both +/+ and W/W-v mice. Administration of monoclonal anti-IL-4 antibody completely prevented the fatal reactions, and the effect of anti-IL-4 was associated with its suppressive activity on Pen V-specific serum levels of IgE, but not IgG. The platelet-activating factor (PAF) antagonist, BN 50739, completely prevented the fatal reactions in both strains of mice. Our kinetic study revealed, in contrast to no elevation of plasma histamine level in W/W-v mice, high levels of PAF in the circulation after challenge in both +/+ and W/W-v mice, albeit to a lesser degree in the latter case. These data indicate that cells other than mast cells are sufficient to induce an IgE-dependent active fatal anaphylaxis by elaborating PAF, which is the critical mediator for fatal murine anaphylaxis.
引用
收藏
页码:1587 / 1592
页数:6
相关论文
共 37 条
[1]   PRODUCTION OF ACTIVE AND PASSIVE ANAPHYLACTIC SHOCK IN THE WBB6F1 MOUSE, A MAST CELL-DEFICIENT STRAIN [J].
ARIMURA, A ;
NAGATA, M ;
WATANABE, A ;
NAKAMURA, K ;
TAKEUCHI, M ;
HARADA, M .
EXPERIENTIA, 1990, 46 (07) :739-742
[2]   HUMAN EPIDERMAL LANGERHANS CELLS EXPRESS THE HIGH-AFFINITY RECEPTOR FOR IMMUNOGLOBULIN-E (FC-EPSILON-RI) [J].
BIEBER, T ;
DELASALLE, H ;
WOLLENBERG, A ;
HAKIMI, J ;
CHIZZONITE, R ;
RING, J ;
HANAU, D ;
DELASALLE, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (05) :1285-1290
[3]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[4]  
BRAQUET P, 1985, LANCET, V1, P1501
[5]   TUMOR NECROSIS FACTOR/CACHECTIN STIMULATES PERITONEAL-MACROPHAGES, POLYMORPHONUCLEAR NEUTROPHILS, AND VASCULAR ENDOTHELIAL-CELLS TO SYNTHESIZE AND RELEASE PLATELET-ACTIVATING-FACTOR [J].
CAMUSSI, G ;
BUSSOLINO, F ;
SALVIDIO, G ;
BAGLIONI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1390-1404
[6]   Differentiation of eosinophils from cord blood cell precursors: Kinetics of Fc epsilon RI and Fc epsilon RII expression [J].
Capron, M ;
Morita, M ;
Woerly, G ;
Lengrand, F ;
Gounni, AS ;
Delaporte, E ;
Capron, A .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 113 (1-3) :48-50
[7]   ROLE OF PLATELET-ACTIVATING FACTOR IN PLATELET-AGGREGATION [J].
CHIGNARD, M ;
LECOUEDIC, JP ;
TENCE, M ;
VARGAFTIG, BB ;
BENVENISTE, J .
NATURE, 1979, 279 (5716) :799-800
[8]  
CHOI IH, 1995, CLIN EXP IMMUNOL, V100, P390
[9]   Lack of Fc-epsilon receptors on murine eosinophils: Implications for the functional significance of elevated IgE and eosinophils in parasitic infections [J].
deAndres, B ;
Rakasz, E ;
Hagen, M ;
McCormik, ML ;
Mueller, AL ;
Elliot, D ;
Metwali, A ;
Sandor, M ;
Britigan, BE ;
Weinstock, JV ;
Lynch, RG .
BLOOD, 1997, 89 (10) :3826-3836
[10]   Absence of Fc(epsilon)RI alpha chain results in upregulation of Fc gamma RIII-dependent mast cell degranulation and anaphylaxis - Evidence of competition between Fc(epsilon)RI and Fc gamma RIII for limiting amounts of FcR beta and gamma chains [J].
Dombrowicz, D ;
Flamand, V ;
Miyajima, I ;
Ravetch, JV ;
Galli, SJ ;
Kinet, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :915-925